Adherence and Risk Behaviour in Patients With HIV Infection Receiving Antiretroviral Therapy
ARB
1 other identifier
observational
700
1 country
1
Brief Summary
Study Hypothesis: Do certain risk behaviours impact/predict levels of HIV antiretroviral adherence? Objectives:
- To assess risk behavior in HIV-positive individuals receiving highly active antiretroviral therapy.(HAART)
- To assess levels of adherence in the same subjects at the same time point
- To determine if there is a correlation between HAART adherence and risk behaviour
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2007
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 2, 2007
CompletedFirst Posted
Study publicly available on registry
August 3, 2007
CompletedStudy Start
First participant enrolled
September 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedJuly 17, 2020
July 1, 2020
1.3 years
August 2, 2007
July 15, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The relationship between sexual risk behavior and adherence to HIV medications and how do these behaviors relate to patient beliefs about HIV transmission.
2 Years
Study Arms (1)
HIVNAT 006
HIVNAT 006 is a long term follow up cohort. The primary objective of this study is to collect and evaluate the long-term clinical outcomes of HIV infected patients have participated in HIV-NAT studies. These subjects will be used to test our hypothesis.
Eligibility Criteria
Approximately 500 subjects were surveyed from the HIVNAT 006 long term follow up cohort. A sample size as large as this is likely to yield accurate results as to the true relationship between sexual risk behavior and adherence to HIV medications.
You may qualify if:
- Age ≥ 18 years
- HIV seropositive.
- On continuous HAART for at least 6 months
- Signed written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
HIV-NAT, Thai Red Cross AIDS Research Centre
Bangkok, 10330, Thailand
Related Publications (1)
Honeybrook AL. Adherence and Risk Behaviour in Patients With HIV Recieving antiretroviral therapy. XVII International AIDS Conference 2008. Mexico City, Mexico.
RESULT
Related Links
Biospecimen
Blood samples required to provide Viral Load data and CD4 cell count
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kiat Ruxrungtham, M.D., M.Sc.
HIVNAT
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 2, 2007
First Posted
August 3, 2007
Study Start
September 1, 2007
Primary Completion
January 1, 2009
Study Completion
December 1, 2009
Last Updated
July 17, 2020
Record last verified: 2020-07